Uterine Papillary Serous Cancer (UPSC) Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

June 30, 2008

Study Completion Date

October 31, 2009

Conditions
Uterine Cancer
Interventions
DRUG

Paclitaxel, Carboplatin

Trial Locations (2)

4029

QCGC, Royal Brisbane and Women's Hospital, Herston

4101

Mater Adult Public Hospital, South Brisbane

All Listed Sponsors
lead

Queensland Centre for Gynaecological Cancer

OTHER_GOV

NCT00147680 - Uterine Papillary Serous Cancer (UPSC) Trial | Biotech Hunter | Biotech Hunter